Use this URL to cite or link to this record in EThOS:
Title: Monocyte C1-inhibitor synthesis
Author: Jones, Linda Margaret
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 1987
Availability of Full Text:
Access from EThOS:
Access from Institution:
C1-inhibitor is the major control protein of the classical pathway of complement. In man, its hereditary deficiency results in the clinical condition of hereditary angio-oedema (HAE). The disease is characterised by recurrent episodes of acute, circumscribed, non-inflammatory oedema involving the subcutaneous tissues and mucous membranes. Acquired C1-inhibitor deficiency can also occur without any previous family history, at a later stage in life and is usually associated with a lymphoproliferative disorder or paraproteinaemia. C1-inhibitor deficiency is treated by the administration of anabolic steroids, such as danazol or stanozolol, which are known to increase hepatic synthesis of C1-inhibitor, resulting in an increase in plasma C1-inhibitor.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available